Mesoblast's Cell Therapy for Graft-Versus-Host Disease Wins FDA Approval; Stock Soars 42%The FDA has approved Mesoblast Limited's (NASDAQ: MESO) Ryoncil (remestemcel-L), marking it as the first mesenchymal stromal cell (MSC) therapy in the U.S. and the sole treatment for steroid-refractory acute gra...
FedEx Stock Soars on Freight Business Spin-Off PlansFedEx (FDX) shares surged in extended trading on Thursday after the company announced plans to spin off its Freight business into a standalone entity. The separation process is set to begin immediately and is expected to be completed within 18 months.“We believe this separation will unlock significant value for stockholders,” said FedEx CEO R...
Accenture Stock Rises as Earnings Beat Estimates and AI Drives GrowthAccenture (ACN) shares jumped 7% on Thursday after the company reported first-quarter earnings that surpassed expectations and raised its full-year revenue forecast.The firm posted $17.7 billion in revenue, up from $16.2 billion a year ago and ahead of analysts' estimates of $17.1 billion. Net income rose to $2.28 billion ($3.59 ...
